KARO BIO
DEAD

Serial Number

76311858

Owner

KARO BIO AB

Attorney

Francis J. Duffin

Filing Date

Sep 12, 2001

Add to watchlist:

No watchlists yet
View on USPTO

KARO BIO Trademark

Serial Number: 76311858 • Registration: 3390490

KARO BIO is a trademark filed by KARO BIO AB on September 12, 2001. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

KARO BIO AB (8 trademarks)

57 HUDDINGE
NOVUM, S-141 , SE

Entity Type: 03

Trademark Details

Filing Date

September 12, 2001

Registration Date

March 4, 2008

Published for Opposition

March 23, 2004

Cancellation Date

October 10, 2014

Goods & Services

Pharmaceutical preparations for the treatment of metabolic disorders such as diabetes, obesity and hypercholesterolemia, cardiovascular diseases, congenital heart failure, cardiac arrhythmia, atrial fibrillation and hypertension, osteoporosis, menopause, puberty and urogenital atrophy, male hormone deficiency, cancer, ophthalmology, skin disorders, inflammatory disorders and bacterial infections; pharmaceutical substances, namely dermatological creams for the treatment of skin disorders; veterinary preparations for the treatment of metabolic disorders such as diabetes, obesity and hypercholesterolemia, cardiovascular diseases, congenital heart failure, cardiac arrhythmia, atrial fibrillation and hypertension, osteoporosis, menopause, puberty and urogenital atrophy, male hormone deficiency, cancer, ophthalmology, skin disorders, inflammatory disorders and bacterial infections; veterinary substances, namely, dermatological creams for use in the treatment of skin disorders, medicinal preparations for the treatment of metabolic disorders such as such as diabetes, obesity and hypercholesterolemia, cardiovascular diseases, congenital heart failure, cardiac arrhythmia, atrial fibrillation and hypertension, osteoporosis, menopause, puberty and urogenital atrophy, male hormone deficiency, cancer, ophthalmology, skin disorders, inflammatory disorders and bacterial infections; medicinal substances, namely, dermatological cream for the treatment of skin disorders; medical diagnostic reagents; diagnostic agents for veterinary use; clinical medical reagents, namely, reagents for clinical-chemical tests; diagnostic reagents for clinical or medical laboratory use; vaccines; transdermal drug patches sold with medication for the treatment of metabolic disorders such as diabetes, obesity and hypercholesterolemia, cardiovascular diseases, congenital heart failure, cardiac arrhythmia, atrial fibrillation and hypertension, stroke, peripheral vascular disease, thromboembolism, retenosis of catheterization or surgical repairs, osteoporosis, menopause, puberty and urogenital atrophy, male hormone deficiency, cancer, ophthalmology, skin disorders, inflammatory disorders and bacterial infections; diagnostic kits for medical and veterinary purposes, namely, assays and reagents for the identification of compounds that bind and/or modulate one or more biologically active substances, such as receptors and enzymes, for the identification of the biological activity of biologically active substances, such as enzymes and receptors and to identify antibacterial compounds

Chemical reagents for scientific or research use, namely, assays for identification of compounds that bind and/or modulate one or more biologically active substances, such as receptors and enzymes, assays for the identification of the biological activity of biologically active substances, such as enzymes or receptors, assays for the identification of antibacterial compounds, compounds capable of modulating the biological activity of a biologically active substance, such as an enzyme or a receptor, and tissue culture growth media; chemical preparations for use in medical research, namely, reagents for the identification of compounds that bind and/or modulate one or more biologically active substances, such as receptors and enzymes, assays for the identification of the biological activity of biologically active substances such as enzymes or receptors; assays for the identification of antibacterial compounds, compounds capable of modulating the biological activity of a biologically active substance, such as an enzyme or a receptor; biochemicals for industrial purposes, namely, tissue culture growth media; chemical and biological substances for use in the manufacture of medicinal, pharmaceutical and veterinary products

Diagnostic apparatus for medical and veterinary purposes, namely, apparatus used in identifying compounds that bind and/or modulate one or more biologically active substances, such as receptors and enzymes, for the identification of the biological activity or biologically active substances, such as receptors and enzymes, and to identify antibacterial compounds

Pharmaceutical research services; pharmaceutical advisory services; scientific research project management; scientific and industrial research; medical laboratory services; medical research; provision of medical information; veterinary laboratory services

Filing History

CANCELLED SEC. 8 (6-YR)
Oct 10, 2014 C8..
REGISTERED-PRINCIPAL REGISTER
Mar 4, 2008 R.PR
1(B) BASIS DELETED; PROCEED TO REGISTRATION
Jan 30, 2008 DP1B
REVIEW OF CORRESPONDENCE COMPLETE
Jan 30, 2008 CORV
PAPER RECEIVED
Oct 29, 2007 MAIL
NOTICE OF ALLOWANCE CANCELLED
Jun 15, 2006 IUCN
TEAS DELETE 1(B) BASIS RECEIVED
Jun 5, 2006 D1BR
SOU EXTENSION 3 GRANTED
Jan 9, 2006 EX3G
SOU EXTENSION 3 FILED
Dec 7, 2005 EXT3
SOU TEAS EXTENSION RECEIVED
Dec 7, 2005 EEXT
SOU EXTENSION 2 GRANTED
Jun 20, 2005 EX2G
SOU EXTENSION 2 FILED
Jun 13, 2005 EXT2
SOU TEAS EXTENSION RECEIVED
Jun 13, 2005 EEXT
SOU EXTENSION 1 GRANTED
Dec 22, 2004 EX1G
SOU EXTENSION 1 FILED
Dec 14, 2004 EXT1
SOU TEAS EXTENSION RECEIVED
Dec 14, 2004 EEXT
CASE FILE IN TICRS
Aug 20, 2004 CFIT
NOA MAILED - SOU REQUIRED FROM APPLICANT
Jun 15, 2004 NOAM
PUBLISHED FOR OPPOSITION
Mar 23, 2004 PUBO
NOTICE OF PUBLICATION
Mar 3, 2004 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 9, 2004 CNSA
EMAIL RECEIVED
Dec 23, 2003 EMRV
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 22, 2003 CRFA
NON-FINAL ACTION MAILED
Jul 3, 2003 CNRT
UNRESPONSIVE/DUPLICATE PAPER RECEIVED
May 14, 2003 UNPR
SEC. 44(D) CLAIM DELETED
Apr 10, 2003 44DD
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 10, 2003 CRFA
PAPER RECEIVED
Apr 10, 2003 MAIL
LETTER OF SUSPENSION MAILED
Feb 25, 2003 CNSL
ASSIGNED TO EXAMINER
Feb 24, 2003 DOCK
PAPER RECEIVED
Dec 23, 2002 MAIL
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 4, 2002 CRFA
NON-FINAL ACTION MAILED
Nov 28, 2001 CNRT
ASSIGNED TO EXAMINER
Nov 15, 2001 DOCK